Attendees will have the opportunity to register for the in-person meeting in San Diego or via one of the virtual registration options.If you choose to participate in person, you will also receive complimentary access to the annual meeting virtual platform through January 1, 2024 (with the opport...
The premier event in classical and malignant hematology is coming to San Diego! The ASH Annual Meeting and Exposition will take place in December 2023 and 2024 Registration is now open. Listed In Medical & Pharma #research #Advocacy #vascular #disorder You...
2023年12月9日~12日,第65届美国血液学年会(ASH)将在美国圣迭戈以“线上+线下”的形式隆重召开。作为全球血液学领域规模最大、涵盖最全面的国际学术盛会之一,会议围绕红细胞疾病、出凝血疾病、血栓性疾病、血液肿瘤等多领域,涵盖科学项目、科学座谈会、科...
ASH is pleased to offer participants in-person and virtual options to attend the annual meeting. However you choose to participate, your registration includes access to the annual meeting sessions, Q&A, networking, CME/MOC, exhibits, and more. VIRTUAL ACCESS REGISTRATION The ASH annual meeting virt...
2024 Annual Meeting Recruitment Event SNPhA x ACCP Virtual Showcase EDUCATION & MEETINGS Overview Specialty Certification Examination Preparation Specialty Recertification ACCP Academy ACCP Professional Leadership Advanced Pharmacy Practice Experience (APPE) ...
通过促进对血液学的研究、临床护理、教育、培训和宣传,进而促进对血液、骨髓、免疫、止血和血管系统疾病的了解、诊断与防治。2022年美国血液学会年会日程,2022 Schedule-at-a-Glance ASH ANNUAL MEETING & EXPOSITION 注册信息 第64 届 ASH 年会暨博览会将于 2022 年 12 月 10 日至 13 日在路易斯安那州新奥尔良...
survival benefits of front-line AYVAKIT use in patients with advanced SM, and support Blueprint Medicines' plans to evaluate novel clinical measures indicative of disease modification – such as bone density and biomarkers...
undergoing hematopoietic stem cell transplantation, and comprehensive data from the first seven cohorts of the ongoing phase 1/2a dose-escalation study of MP0533. The data are presented in two posters at theAmerican Society of Hematology(ASH) annual meeting, being heldDecember 7-10...
Early-bird registration is open from April,1st, 2023. Abstract submissions for oral and e-poster presentations are also welcome. I look forward to welcoming you to Bangkok, and meeting you all in person. Sincerely Yours, Patravoot Vatanasapt, MD, PhD, FRCOT ...
2023 - Planned Interim Safety Analysis of the Phase 3 Randomized Trial of Selinexor and Lenalidomide Versus Lenalidomide Maintenance Post Autologous Stem Cell Transplant for Patients with Newly Diagnosed Multiple Myeloma (ALLG MM23; Sealand) 4641 - Lenalidomide Consolidation Improves Measurable Residual Dise...